Author:
Crapper McLachlan D.R.,Lukiw W.J.,Kruck T.P.A.
Abstract
ABSTRACT:Application of molecular biological techniques and sensitive elemental analysis have produced new evidence implicating aluminum as an important factor in down regulation of neuronal protein metabolism. Aluminum in Alzheimer's disease may act by electrostatically crosslinking proteins, particularly the methionine containing histone Hl°, and DNA. The consequence of such crosslinking is reduced transcription of at least one neuron specific gene, the low molecular weight component of neurofilaments. In the superior temporal gyrus in Alzheimer's disease, down regulation of this gene occurs in approximately 86% of surviving neurons and, therefore, aluminum must be considered as having an active role in the pathogenesis. Epidemiological studies are reviewed that independently support the hypothesis that environmental aluminum is a significant risk factor. Preliminary evidence also suggests that a disorder in phosphorylation may be an important initiating factor.
Publisher
Cambridge University Press (CUP)
Subject
Clinical Neurology,Neurology,General Medicine
Reference65 articles.
1. brain concentrations in Alzheimer’s disease;Markesbery;Aluminum Analysis in Biological Materials,1983
2. Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging
3. Brain aluminum in Alzheimer’s disease: Influence of sample size and case selection;Crapper Mclachlan;Neurotoxicology,1980
4. Brain aluminum in aging and Alzheimer disease
Cited by
89 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献